AbbVie, Lilly Face Fresh Delays in FDA Approval for Expanded Use of Arthritis Drugs
07/23/2021

AbbVie, Lilly Face Fresh Delays in FDA Approval for Expanded Use of Arthritis Drugs

(Reuters) – AbbVie Inc and Eli Lilly & Co are facing fresh delays in the approval of their...
read more